Terra Reynolds > Latham & Watkins LLP > Silicon Valley, United States > Lawyer Profile

The interdisciplinary team at Latham & Watkins LLP flexes its muscles across regulatory, transactional, and contentious healthcare law matters, notably representing some of the country’s most prominent health insurance carriers in high-stakes litigation. The group is led by a DC trio of John Manthei, Ben Haas, and Jason Caron, and Chicago-based partner Terra Reynolds. The department has experience handling M&A and large-scale transactions in the healthcare space, managing lawsuits regarding Medicare Advantage regulation, and supporting clients facing government agency investigations and disputes, in addition to a range of other matters. Former General Counsel of the United States Department of Health and Human Services Daniel Meron contributes deep regulatory and investigatory expertise to the practice, and David Tolley assists insurers facing government investigations as well as representing them in court.

Latham & Watkins LLP offers strategic guidance to clients navigating complex regulatory challenges, government investigations, and high-stakes litigations. The firm’s white-collar practice specializes in handling matters related to securities fraud, antitrust violations, bribery, and other matters. Alice S. Fisher, a leading lawyer in the white-collar field, is highly regarded for her extensive expertise in corporate investigations and enforcement matters. She is joined by Douglas Greenburg, who brings great experience in white-collar criminal matters and SEC enforcement proceedings. Both are based in Washington DC  and are celebrated for their impressive legal acumen and leadership within their respective areas of specialization. Kevin Andrew Chambers  in Washington DC who draws on government experience to represent clients in white-collar, securities, and professional liability matters. Terra Reynolds  in Chicago focuses on healthcare and life sciences, defending clients against healthcare fraud allegations, including the FCA and AKS. Doug Yatter in New York advises clients in financial services and fintech on government inquiries, internal investigations, and regulatory issues. Jude Volek , Benjamin Naftalis also in New York represent clients in regulatory enforcement matters, government and internal investigations.  Jennifer Bragg , William McConagha, and Margaret Graham joined in 2024, and Jason Ohta was promoted in 2024, further strengthening the firm’s bench.

Primarily based in Washington DC, the practice at Latham & Watkins LLP stands out for its strength in healthcare private equity transactions, healthcare system bankruptcies, and 340B program issues. John Manthei, Ben Haas, Jason Caron, and Terra Reynolds jointly lead the practice. Caron often advises health systems and private investors on affiliations, public mergers, and joint ventures, and California’s Heather Deixler is well-known for her deep knowledge of genetic and de-identified data and its use in compliance with HIPAA and HITECH. In Chicago, Reynolds is noted for handling white-collar crime issues within the healthcare sector. Joseph Hudzik is a key contact for healthcare fraud and abuse compliance work. David Tolley works out of the Boston office, and regularly represents insurers, hospital systems, and pharmacy benefit managers in FCA and AKS investigations and disputes.

Latham & Watkins LLP’s client base ranges from globally recognized life sciences businesses to biopharma and biotech start-ups. The busy practice is active across a range of life sciences industry sectors, from pharmaceuticals and biotechnology to cosmeceuticals and food tech. The team’s key areas of activity include complex corporate transactions such as M&A, with experts including Julie Scallen. Also on the transactional side, Shayne Kennedy focuses on capital markets along with Matthew Bush and Nathan Ajiashvili, while Cheston Larson advises on financing. Through its development of licensing structures and facilitation of commercial transactions, the team has been active in the funding of drug development and commercialization. The firm also handles litigation matters such as IP disputes, counting on experts such as Arlene Chow, as well as regulatory and legislative strategies; Ben Haas is a key figure in the latter. Among the practice’s key figures are also John Manthei and Elizabeth M. Richards, both experts in FDA regulatory matters, and Terra Reynolds, in white-collar defense and investigations. In 2024, litigation and regulatory specialists Jennifer L. Bragg and William McConagha joined the practice from Skadden, Arps, Slate, Meagher & Flom LLP, and in April 2025, Kate Hillier  joined from Cooley LLP.